{
    "2021-01-08": [
        [
            {
                "time": "",
                "original_text": "健帆生物2020年预计盈利超7.99亿 加速渗透国内市场产品覆盖5400家医院",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "2020年",
                        "预计盈利",
                        "7.99亿",
                        "加速渗透",
                        "国内市场",
                        "产品覆盖",
                        "5400家医院"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "42股获券商买入评级 中国长城目标涨幅达57.14%",
                "features": {
                    "keywords": [
                        "42股",
                        "券商",
                        "买入评级",
                        "中国长城",
                        "目标涨幅",
                        "57.14%"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "军工"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}